Frequent involvement of central nervous system in primary Sjögren syndrome

被引:0
作者
Isabel Moreira
Filipa Teixeira
Ana Martins Silva
Carlos Vasconcelos
Fátima Farinha
Ernestina Santos
机构
[1] Hospital Santo António,Neurology Department
[2] Centro Hospitalar do Porto,Rheumatology Department
[3] Unidade Local de Saude do Alto Minho,Clinical Immunology Unit
[4] Hospital Santo António,undefined
[5] Centro Hospitalar do Porto,undefined
来源
Rheumatology International | 2015年 / 35卷
关键词
Sjögren syndrome; Sicca syndrome; Autoimmune diseases; Central nervous system; Neuroimmune process; Keratoconjunctivitis sicca;
D O I
暂无
中图分类号
学科分类号
摘要
Primary Sjögren syndrome (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and tear glands, and autoantibody secretion, in the absence of other systemic autoimmune disorder. Among autoimmune diseases, it is a relatively common disease, but the burden of central nervous system (CNS) involvement is controversial. This retrospective study evaluates the prevalence, clinical patterns and outcomes of CNS involvement in a cohort of patients with primary Sjögren syndrome. We evaluated 93 patients with pSS diagnosed according to American-European Consensus Group criteria. Fourteen patients (15.1 %) had CNS involvement. All were women with an average age of onset of the disease of 42.1 ± 14.7 years (average ± SD) and an average age of onset of neurological involvement of 47.29 ± 16 years. Three had parkinsonian syndrome, two epilepsy, two motor and sensory deficits, two headache with brain magnetic resonance abnormalities, two neuromyelitis optica, two chronic progressive myelitis and one aseptic meningitis. Neurological involvement preceded Sjögren syndrome diagnosis in nine of the patients (64 %), and neurological outcome was good in 11 patients (78.6 %). Central nervous involvement was not as rare as expected, and the frequency was similar to the frequency of peripheral nervous system involvement. In half of the patients, this was the first symptom of the disease, emphasizing the importance of considering this diagnosis, especially in young female with neurological symptoms without other evident cause.
引用
收藏
页码:289 / 294
页数:5
相关论文
共 39 条
[1]  
Mavragani CP(2010)The geoepidemiology of Sjögren’s syndrome Autoimmun Rev 9 A305-A310
[2]  
Moutsopoulos HM(2004)Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients Medicine (Baltimore) 83 280-291
[3]  
Delalande S(2002)Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 554-558
[4]  
de Seze J(2013)Neurological involvement in primary Sjögren’s syndrome Acta Reumatol Port 38 29-36
[5]  
Fauchais AL(2011)Clinical manifestations of neurological involvement in primary Sjogren’s syndrome Clin Rheumatol 30 485-490
[6]  
Vitali C(2010)Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable—clinical, serological characteristics and outcomes in a large cohort of Italian patients Rheumatology (Oxford) 49 1540-1549
[7]  
Bombardieri S(2008)Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients Medicine (Baltimore) 87 210-219
[8]  
Jonsson R(2005)Primary Sjogren’s syndrome: clinical and serological feature of a single centre Reumatismo 57 256-261
[9]  
Teixeira F(2004)Primary Sjögren’s syndrome: exocrine and non-exocrine manifestations Rev Bras Reumatol 44 129-138
[10]  
Moreira I(2002)Primary Sjogren Syndrome: clinical and immunologic disease patterns in a cohort of 400 patients Medicine (Baltimore) 81 270-280